+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Cell Therapy Market by Use Type, by Therapy Type, and by Region - Global Forecast to 2023-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717268
The cell therapy market size is estimated to be USD 7,952.4 million in 2022 and is expected to witness a CAGR of 14.81% during the forecast period 2023-2033. Increasing popularity of stem cell therapies among end users, therapeutic benefits of these treatments over conventional medicines, and rising R&D spending in stem cell therapies are projected to drive the market growth in near future. Furthermore, advancements in regenerative medicine and gradually emerging new technologies that support the development of innovative therapies are other factors supporting the market growth. However, high price of cell therapies and a shortage of skilled workers are predicted to limit market growth are expected to restrain the market growth.

Advancements in regenerative medicine is expected to fuel the market growth during the projected period. To take advantage of the untapped potential of the market for cell treatment, some companies are leading the way in developing nations including Canada. RepliCel is one company that is funding numerous regenerative medicine studies. For instance, the company revealed plans in February 2021 to commercialize and test three new innovations in Japan. One of them is for tendon regeneration, while the other is for skin rejuvenation. Both are cell-based therapies.

Gradually emerging new technologies that support the development of innovative therapies is predicted to propel the market growth during the forecast period. A single product can be used to produce a strong portfolio of candidates most effectively through the introduction of proprietary cell lines, which is the major method. For instance, to expand their product line for immuno-oncology, Immunicum uses T-cell primers, chimeric antigen receptor T cell (CAR-T) expansion, and dendritic cell neoantigen presentation technology. Additionally, direct cell reprogramming has attracted a lot of interest as a cutting-edge therapeutic approach.

Segmentation

By Use Type

The market is categorized into research use and clinical use. In 2022, the research use segment accounted for the highest revenue share due to the fact autosamplers being used more frequently due to the expanding R&D initiatives. Additionally, major market participants are actively funding research initiatives. Governmental organizations are working together on research projects involving cells, in addition to market participants. These factors collectively are fueling the segment's expansion. For replacing, regenerating damaged tissues, repairing, and organs, cell-based therapies have significant potential. As an alternative to traditional treatment modalities, researchers are investing huge resources into the development of such efficient and safe treatments. The clinical-use segment is predicted to increase at a constant rate throughout the course of the forecast year due to its lower penetration. However, only a small number of cell treatments, including Invossa, CARTISTEM, Epicel, Cellgram-AMI, MACI, and Imlygic have received approval for use in clinical settings. This is expected to spur commercial interests in this market.

By Therapy Type

The market is divided into autologous therapies and allogenic therapies. In the global market, the autologous therapies segment accounted for the largest revenue share in 2022 due to the number of benefits of autologous transplants, including their accessibility, no requirement to find an HLA-matched donor, absence of the risk of GVHD, reduced risk of serious consequences, and lack of the need for immunosuppressive medication. Additionally, autologous therapies are more affordable than allogenic therapies, which contributes to the segment's expansion. The allogenic therapies segment is predicted to increase relatively slow due to the high price of allogenic transplants and the very low relapse rates. The market for cell therapy is being driven by the expansion of cell banking and the shift in company focus towards the creation of allogenic therapeutic solutions.

Regional Markets

In 2022, North America region accounted for the highest revenue in the cell therapy market and is expected to maintain its dominance during the forecast period. This is attributed to existence of numerous centres and institutes working on stem cell treatment research and development. The Asia Pacific cell therapy market is predicted to expand at a profitable growth rate over the course of the forecast period. The growing investment made by manufacturers and consumers in educating themselves about cutting-edge medical therapies is expected to increase the revenue from the region's developing economies. Asian nations have a number of stem cell consortiums that work to ensure coordinated and targeted R&D initiatives. In addition, due to the adaptable legal systems in Asia, patients from western nations are reported to go there for medical treatment.

Competitor Insights

Some of the key players operating in the cell therapy market are PHARMICELL Co., Ltd., MEDIPOST,
Anterogen Co., Ltd., JCR Pharmaceuticals Co., Ltd., Castle Creek Biosciences, Inc., Osiris Therapeutics, Inc., Cells for Cells, Vericel Corporation, Tameika Cell Technologies, Inc., Kolon TissueGene, Inc., NuVasive, Inc., The Future of Biotechnology, and Celgene Corporation.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

The FDA approved KIMMTRAK Immunocore's treatment for advanced and metastatic uveal melanoma in January 2022.

In order to assist patients in the U.S. and Europe in making the transition from the clinic to the commercial release, Thermo Fisher Scientific announced the launch of complete and integrated commercial packaging and distribution services in February 2022. In order to support their logistics strategy, programmers can now use Patheon Commercial Packaging Services, a new end-to-end solution.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including user type and therapy type from 2022 to 2033.

Segmentation: Cell Therapy Market Report 2022 - 2033

User Type (Revenue, USD Million), 2022 - 2033

  • Research Use

Clinical Use

  • By Therapeutic Area
  • Musculoskeletal Disorders
  • Malignancies
  • Dermatology
  • Autoimmune Disorders

Others

  • By Cell Type
  • Non-stem Cell Therapies

Stem Cell Therapies

  • Adipose-derived Cells
  • BM, Blood, & Umbilical cord-derived Stem Cells
  • Others

Therapy Type (Revenue, USD Million), 2022 - 2033

  • Autologous Therapies
  • Allogenic Therapies

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model

2. Introduction: Cell Therapy

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Cell Therapy Market

7. Market Analysis by User Type
7.1. Research Use
7.1.1. Research Use Market Forecast, 2022-2033 (USD Million)
7.2. Clinical Use
7.2.1. Clinical Use Market Forecast, 2022-2033 (USD Million)
7.2.1.1. Therapeutic Area
7.2.1.1.1. Therapeutic Area Market Forecast, 2022-2033 (USD Million)
7.2.1.1.1.1. Musculoskeletal Disorders
7.2.1.1.1.1.1. Musculoskeletal Disorders Market Forecast, 2022-2033 (USD Million)
7.2.1.1.1.2. Malignancies
7.2.1.1.1.2.1. Malignancies Market Forecast, 2022-2033 (USD Million)
7.2.1.1.1.3. Dermatology
7.2.1.1.1.3.1. Dermatology Market Forecast, 2022-2033 (USD Million)
7.2.1.1.1.4. Autoimmune Disorders
7.2.1.1.1.4.1. Autoimmune Disorders Market Forecast, 2022-2033 (USD Million)
7.2.1.1.1.5. Others
7.2.1.1.1.5.1. Others Market Forecast, 2022-2033 (USD Million)
7.2.1.2. Cell Type
7.2.1.2.1. Cell Type Market Forecast, 2022-2033 (USD Million)
7.2.1.2.1.1. Non-stem Cell Therapies
7.2.1.2.1.1.1. Stem Cell Therapies Market Forecast, 2022-2033 (USD Million)
7.2.1.2.1.2. Stem Cell Therapies
7.2.1.2.1.2.1. Stem Cell Therapies Market Forecast, 2022-2033 (USD Million)
7.2.1.2.1.2.1. Adipose-derived Cells
7.2.1.2.1.2.1.1. Adipose-derived Cells Market Forecast, 2022-2033 (USD Million)
7.2.1.2.1.2.2. BM, Blood, & Umbilical cord-derived Stem Cells
7.2.1.2.1.2.2.1. BM, Blood, & Umbilical cord-derived Stem Cells Market Forecast, 2022-2033 (USD Million)
7.2.1.2.1.2.3. Others
7.2.1.2.1.2.3.1. Others Market Forecast, 2022-2033 (USD Million)



8. Market Analysis by Therapy Type
8.1. Allogenic Therapies
8.1.1. Allogenic Therapies Market Forecast, 2022-2033 (USD Million)
8.2. Autologous Therapies
8.2.1. Autologous Therapies Market Forecast, 2022-2033 (USD Million)

8. Regional Market Analysis
8.1. Regional Market Trends

9. North America Cell Therapy Market
9.1. North America Cell Therapy Market
9.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
9.1.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
9.1.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
9.2. U.S. Cell Therapy Market
9.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Million)
9.2.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
9.2.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
9.3. Canada Cell Therapy Market
9.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
9.3.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
9.3.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)

10. Europe Cell Therapy Market
10.1. Europe Cell Therapy Market
10.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
10.1.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
10.1.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
10.2. Germany Cell Therapy Market
10.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
10.2.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
10.2.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
10.3. UK Cell Therapy Market
10.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
10.3.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
10.3.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
10.4. France Cell Therapy Market
10.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
10.4.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
10.4.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
10.5. Spain Cell Therapy Market
10.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
10.5.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
10.5.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
10.6. Italy Cell Therapy Market
10.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
10.6.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
10.6.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
10.7. Rest of Europe Cell Therapy Market
10.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
10.7.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
10.7.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)

11. Asia Pacific Cell Therapy Market
11.1. Asia Pacific Cell Therapy Market
11.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
11.2. Japan Cell Therapy Market
11.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
11.3. China Cell Therapy Market
11.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
11.4. India Cell Therapy Market
11.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
11.4.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
11.4.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
11.5. South Korea Cell Therapy Market
11.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
11.5.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
11.5.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
11.5.1.3. Market Size and Forecast by Device, 2022-2033 (USD Million)
11.6. Australia Cell Therapy Market
11.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
11.6.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
11.6.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
11.7. Rest of Asia Pacific Cell Therapy Market
11.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.7.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
11.7.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)

12. Latin America Cell Therapy Market
12.1. Latin America Cell Therapy Market
12.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
12.2. Brazil Cell Therapy Market
12.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
12.3. Mexico Cell Therapy Market
12.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
12.4. Argentina Cell Therapy Market
12.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
12.5. Rest of Latin America Cell Therapy Market
12.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)

13. MEA Cell Therapy Market
13.1. MEA Cell Therapy Market
13.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
13.2. GCC Cell Therapy Market
13.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
13.3. South Africa Cell Therapy Market
13.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)
13.4. Rest of MEA Cell Therapy Market
13.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by User Type, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by Therapy Type, 2022-2033 (USD Million)

14. Competitor Analysis
14.1. Market Share Analysis, 2022
14.2. Major Recent Developments, 2019-2022

15. Company Profiles
15.1. PHARMICELL Co., Ltd.
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financials
15.1.4. Product Benchmarking
15.1.5. Recent Developments
15.2. MEDIPOST
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financials
15.2.4. Product Benchmarking
15.2.5. Recent Developments
15.3. Anterogen Co., Ltd.
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financials
15.3.4. Product Benchmarking
15.3.5. Recent Developments
15.4. JCR Pharmaceuticals Co., Ltd.
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financials
15.4.4. Product Benchmarking
15.4.5. Recent Developments
15.5. Castle Creek Biosciences, Inc.
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financials
15.5.4. Product Benchmarking
15.5.5. Recent Developments
15.6. Osiris Therapeutics, Inc.
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financials
15.6.4. Product Benchmarking
15.6.5. Recent Developments
15.7. Cells for Cells
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financials
15.7.4. Product Benchmarking
15.7.5. Recent Developments
15.8. Vericel Corporation
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financials
15.8.4. Product Benchmarking
15.8.5. Recent Developments
15.9. Tameika Cell Technologies, Inc.
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financials
15.9.4. Product Benchmarking
15.9.5. Recent Developments
15.10. Kolon TissueGene, Inc
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financials
15.10.4. Product Benchmarking
15.10.5. Recent Developments
15.11. NuVasive, Inc.
15.11.1. Company Snapshot
15.11.2. Company Overview
15.11.3. Financials
15.11.4. Product Benchmarking
15.11.5. Recent Developments
15.12. The Future of Biotechnology
15.12.1. Company Snapshot
15.12.2. Company Overview
15.12.3. Financials
15.12.4. Product Benchmarking
15.12.5. Recent Developments
15.13. Celgene Corporation
15.13.1. Company Snapshot
15.13.2. Company Overview
15.13.3. Financials
15.13.4. Product Benchmarking
15.13.5. Recent Developments
15.14. Company 14
15.14.1. Company Snapshot
15.14.2. Company Overview
15.14.3. Financials
15.14.4. Product Benchmarking
15.14.5. Recent Developments
15.15. Company 15
15.15.1. Company Snapshot
15.15.2. Company Overview
15.15.3. Financials
15.15.4. Product Benchmarking
15.15.5. Recent Developments
15.16. Others Prominent Players

16. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • PHARMICELL Co. Ltd.
  • MEDIPOST
  • Anterogen Co. Ltd.
  • JCR Pharmaceuticals Co. Ltd.
  • Castle Creek Biosciences Inc.
  • Osiris Therapeutics Inc.
  • Cells for Cells
  • Vericel Corporation
  • Tameika Cell Technologies Inc.
  • Kolon TissueGene Inc.
  • NuVasive Inc.
  • The Future of Biotechnology
  • Celgene Corporation.